Clinical Trials Browser

Phase 2 × Active not recruiting × HER2-positive Breast Cancer × Clear all

NCT03571633 2025-11-26

BREASTIMMU02

Phase 2 Active not recruiting

HER2-positive Breast Cancer

NCT03125928 2025-01-10

Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer

Phase 2 Active not recruiting

HER2-positive Breast Cancer